TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider, has filed for an extension to file its quarterly report. The company filed the extension on Form 10-Q for the second quarter pursuant to a Form 12b-25 filed with the U.S. Securities and Exchange Commission (“SEC”). According to the announcement, TRxADE is “not able to timely file its … Continue reading InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Files Extension for Form 10-Q Filing